Focus on Mesenchymal Stem Cell-Derived Exosomes: Opportunities and Challenges in Cell-Free Therapy.
Lin ChengKun ZhangShuying WuManhua CuiTianmin XuPublished in: Stem cells international (2017)
Mesenchymal stem cells have been at the forefront of regenerative medicine for many years. Exosomes, which are nanovesicles involved in intercellular communication and the transportation of genetic material transportation that can be released by mesenchymal stem cells, have been recently reported to play a role in cell-free therapy of many diseases, including myocardial infarction, drug addiction, and status epilepticus. They are also thought to help ameliorate inflammation-induced preterm brain injury, liver injury, and various types of cancer. This review highlights recent advances in the exploration of mesenchymal stem cell-derived exosomes in therapeutic applications. The natural contents, drug delivery potency, modification methods, and drug loading methods of exosomes are also discussed.
Keyphrases
- mesenchymal stem cells
- cell free
- drug induced
- liver injury
- brain injury
- umbilical cord
- bone marrow
- drug delivery
- cell therapy
- subarachnoid hemorrhage
- circulating tumor
- stem cells
- heart failure
- oxidative stress
- adverse drug
- papillary thyroid
- diabetic rats
- high glucose
- low birth weight
- squamous cell carcinoma
- dna methylation
- lymph node metastasis
- gene expression
- blood brain barrier
- young adults
- copy number
- gestational age
- smoking cessation
- drug release
- cell adhesion